The Medpharm Control Committee together with representatives of the pharmaceutical industry discussed the issues of improving the NPA and the development of the pharmaceutical industry

Today, under the leadership of the Chairman of the Committee of Medical and Pharmaceutical Control of the Ministry of Health of the Republic of Kazakhstan Bauyrzhan Baiserkin, a meeting was held with representatives of pharmaceutical associations, NCE "Atameken" and the National Center for the Examination of Medicines and Medical Products.
During the meeting, issues of revising approaches to the procedure for assessing the quality and selection of medicines and medical products from the market were discussed, as well as special attention was paid to intellectual property issues, improving regulatory legal acts, etc.
As a result of the meeting, a joint decision was made to create a working group to improve the NPA in the field of circulation of medicines and medical products.
As the Chairman of the Committee B. Baiserkin noted, taking into account business appeals and in order to harmonize legislation and develop the pharmaceutical industry, the working group will use a comprehensive approach to develop proposals for optimizing business processes and supporting domestic manufacturers.
The working group includes representatives of the national regulatory authority and the pharmaceutical industry. Meetings of the working group are scheduled to be held regularly.